About the Authors
- Marloes J. M. Gooden
-
Contributed equally to this work with: Marloes J. M. Gooden, Valerie R. Wiersma
Affiliations Department of Surgery, Translational Surgical Oncology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands, Department of Obstetrics and Gynecology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
- Valerie R. Wiersma
-
Contributed equally to this work with: Marloes J. M. Gooden, Valerie R. Wiersma
Affiliation Department of Surgery, Translational Surgical Oncology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
- Douwe F. Samplonius
-
Affiliation Department of Surgery, Translational Surgical Oncology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
- Jurjen Gerssen
-
Affiliation Department of Surgery, Translational Surgical Oncology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
- Robert J. van Ginkel
-
Affiliation Department of Surgery, Translational Surgical Oncology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
- Hans W. Nijman
-
Affiliation Department of Obstetrics and Gynecology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
- Mitsuomi Hirashima
-
Affiliations GalPharma Co., Ltd., Kagawa, Japan, Department of Immunology and Immunopathology, Kagawa University Faculty of Medicine, Kagawa, Japan
- Toshiro Niki
-
Affiliations GalPharma Co., Ltd., Kagawa, Japan, Department of Immunology and Immunopathology, Kagawa University Faculty of Medicine, Kagawa, Japan
- Paul Eggleton
-
¶These authors also contributed equally to this work.
Affiliation University of Exeter Medical School, Exeter, United Kingdom
- Wijnand Helfrich
-
¶These authors also contributed equally to this work.
Affiliation Department of Surgery, Translational Surgical Oncology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
- Edwin Bremer
-
* E-mail: e.bremer@umcg.nl
Affiliation Department of Surgery, Translational Surgical Oncology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
Competing Interests
The authors have the following interests: Drs. Niki and Hirashima are board members of GalPharma Co., Ltd. The authors have a product in development: stable-form galectin-9. Name of the patent: NOVEL MODIFIED GALECTIN 9 PROTEINS AND USE THEREOF. Patent numbers: EP1736541, JP4792390, US8268324. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: DS PE EB WH. Performed the experiments: VW MG DS JG. Analyzed the data: VW EB. Contributed reagents/materials/analysis tools: MH TN PE RVG. Wrote the paper: MG VW EB. Revised the paper: MG VW EB PE HN WH.